Integra LifeSciences Holdings (IART) Reports In-Line Q3 EPS; Cuts FY11 EPS Outlook
Tweet
Share
E-mailGet Alerts IART Hot Sheet
Join SI Premium – FREE
Integra LifeSciences Holdings (NASDAQ: IART) reported Q3 EPS of $0.77, in-line with the analyst estimate of $0.77. Revenue for the quarter came in at $202.2 million versus the consensus estimate of $204.15 million.
Integra sees FY2011 EPS of $2.88-$2.96, versus prior guidance of $2.92-$3.02 and the consensus of $2.93.
Integra sees FY2011 EPS of $2.88-$2.96, versus prior guidance of $2.92-$3.02 and the consensus of $2.93.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus
- Gloo Holdings, Inc. (GLOO) Reports Q1 Loss of $0.21/sh, Updates Guidance
- Academy Sports and Outdoor (ASO) Misses Q1 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
